KLAR Klaria Pharma Holding AB (publ.)

STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · klaria.com

0.5910SEK-2.96%Mkt Cap: 13.91M $P/E: —3d ago

Klaria Pharma Holding AB (publ.), a pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock. Its product pipeline includes Sumatripta…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$64.70BUSDP/E 25.1

TAK

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

$57.06BUSD

TEVA

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$38.70BUSDP/E 18.3

ZTS

Zoetis Inc. Class A Common Stock

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB

$14.24BUSDP/E 109.4

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated Common Stock

$11.06BUSD

RDY

Dr. Reddy's Laboratories Ltd Common Stock

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc. Class A Common Stock

$6.77BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

HIK

Hikma Pharmaceuticals PLC

$4.19BUSDP/E 11.9

Key Statistics

Company

Market Cap13.91M USD

Enterprise Value13.10M USD

Revenue (TTM)9.57K USD

Gross Profit9.57K USD

Net Income (TTM)-4.50M USD

Revenue/Share0.00 SEK

Last Price0.5910 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees4

CountrySE

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINSE0007280326

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-4.77

EV/Revenue1369.06

P/S1453.72

P/B-4.31

EPS (TTM)-0.16

EPS (Forward)0.00

52W Range

0.450016% of range1.330

52W High1.330 SEK

52W Low0.4500 SEK

Profitability

Gross Margin100.00%

Oper. Margin-107530.00%

EBITDA Margin0.00%

Profit Margin-523.75%

ROE390.69%

ROA-144.65%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-3.27M USD

CapEx (TTM)—

FCF Margin-26969.75%

FCF Yield-18.55%

Net Debt-809.98K USD

Net Debt/EBITDA0.29

Balance Sheet

Debt/Equity-2.08

Current Ratio0.20

Quick Ratio0.20

Book Value/Sh-0.14 SEK

Cash/Share0.03 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.245.98M

Float241.34M

Insiders0.00%

Institutions0.01%

Technical

SMA 500.7785 (-24.1%)

SMA 2000.8426 (-29.9%)

Beta1.20

S&P 52W Chg14.58%

Avg Vol (30d)784.83K

Avg Vol (10d)354.74K

Technical Indicators

RSI (14)34.5

MACD-0.0482

MACD Signal-0.0588

MACD Hist.+0.0106

BB Upper0.6237 SEK

BB Middle0.6007 SEK

BB Lower0.5777 SEK

BB Width7.67%

ATR (14)0.0390 SEK

Vol Ratio (20d)0.44x